There were no significant differences in EVs expressing CD3, CD4, CD19, CD11b, CD40, CD41a, CD62P, CD63, CD66b, CD154, CD163, MCSF, CD200, and MAP2 between the cognitive impairment and normal cognition groups (Figure S1). The gene discussed is MAP2; the disease is Cognitive impairment.